1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with Anoxemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olive, PL; Zheng, H | 1 |
| Airley, R; Cowen, RL; Honess, D; Jaffar, M; Patterson, AV; Saunders, M; Stratford, IJ; Telfer, BA; van der Kogel, AJ; Williams, KJ; Wolf, CR | 1 |
| Adams, GE; O'Neill, P; Sheldon, PW; Silver, AR; Stratford, IJ; Walling, JM | 1 |
3 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Anoxemia
| Article | Year |
|---|---|
Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice.
Topics: Animals; DNA; DNA Damage; DNA Repair; Hypoxia; Male; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Sertoli Cells; Spermatids; Spermatocytes; Spleen; Testis; Tumor Cells, Cultured | 1997 |
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.
Topics: Animals; Combined Modality Therapy; Female; Fibrosarcoma; Genetic Therapy; Genetic Vectors; Humans; Hypoxia; Mice; Mice, Nude; Misonidazole; NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Radiation Tolerance; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; DNA; Female; Glutathione; Hydrolysis; Hypoxia; Kinetics; Misonidazole; Oxidation-Reduction; Radiation-Sensitizing Agents; Structure-Activity Relationship; X-Rays | 1986 |